GlassScriptPhysician profile
Kaytlin Denise Wright
NPI 1174147763
$5,932.86
in general payments reported to CMS, 2019-2025
37 companies · $1,814 in 2025
The $1,814 reported for 2025 was more than what 90% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $1,111 · 2023: $1,497 · 2024: $1,170 · 2025: $1,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,463 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,463.40 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,352.45 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $843.87 | 2021-2025 | |
| Lilly USA, LLC | $670.43 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $450.31 | 2021-2025 | |
| Amgen INC. | $313.66 | 2022-2025 | Repatha, Repatha, Evenity |
| Glaxosmithkline, LLC. | $243.43 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $230.52 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Axsome Therapeutics, INC. | $228.27 | 2023-2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $175.94 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.26 | 2021-2025 | Jardiance |
| Exact Sciences Corporation | $153.69 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.02 | 2023-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $93.49 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $91.78 | 2021-2025 | Zoryve, Livalo, Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $72.29 | 2022-2025 | Trintellix |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaytlin Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.